Skip to main content
Log in

Reply to Comment on “A Framework for Fair Pricing of Medicines”

  • Letter to the Editor
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

The Original Article was published on 13 March 2024

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Babar Z. Comment on “A Framework for the Fair Pricing of Medicines”. Pharmacoeconomics. 2024. https://doi.org/10.1007/s40273-024-01368-w.

  2. Paulden M. A framework for the fair pricing of medicines. Pharmacoeconomics. 2024;42:145–64. https://doi.org/10.1007/s40273-023-01325-z.

    Article  PubMed  Google Scholar 

  3. Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016;19:929–35. https://doi.org/10.1016/j.jval.2016.02.017.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Vanness DJ, Lomas J, Ahn H. A health opportunity cost threshold for cost-effectiveness analysis in the United States. Ann Intern Med. 2021;174:25–32. https://doi.org/10.7326/M20-1392.

    Article  PubMed  Google Scholar 

  5. Edney LC, Lomas J, Karnon J, Vallejo-Torres L, Stadhouders N, Siverskog J, et al. Empirical estimates of the marginal cost of health produced by a healthcare system: methodological considerations from country-level estimates. Pharmacoeconomics. 2022;40:31–43. https://doi.org/10.1007/s40273-021-01087-6.

    Article  PubMed  Google Scholar 

  6. Paulden M, O’Mahony J, McCabe C. Determinants of change in the cost-effectiveness threshold. Med Decis Making. 2017;37:264–76. https://doi.org/10.1177/0272989X16662242.

    Article  PubMed  Google Scholar 

  7. Moon S, Mariat S, Kamae I, Pedersen HB. Defining the concept of fair pricing for medicines. BMJ. 2020;368: l4726. https://doi.org/10.1136/bmj.l4726.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mike Paulden.

Ethics declarations

Funding

No funding was received for the preparation of this letter.

Conflicts of Interest/Competing Interests

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paulden, M. Reply to Comment on “A Framework for Fair Pricing of Medicines”. PharmacoEconomics 42, 607–609 (2024). https://doi.org/10.1007/s40273-024-01369-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-024-01369-9

Navigation